Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04802356
Status:
RECRUITING
Last Update Posted:
2021-12-06
First Post:
2021-03-12
Brief Title:
Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Sponsor:
Organization:
PETHEMA Foundation